Powered by

Boehringer Ingelheim Animal Health Assigned Patent for Mammalian Cell Lines

Jul 10, 2019 - Targeted News Service

ALEXANDRIA, Va., July 10 -- Boehringer Ingelheim Animal Health, Duluth, Georgia, and Sanofi, Paris, France, have been assigned a patent (No. 10,345,292, initially filed Sept. 9, 2015) developed by 10 co-inventors for "mammalian cell lines expressing functional nematode acetylcholine receptors and use thereof for high-throughput screening assays." The co-inventors are Lance Hammerland, Brenda Bondesen, Atlanta, Georgia, Jean-Marie Chambard, Yerres, France, Thierry Vermat, Chazayd'Azergues, France...